VeriChip announced today that the Company has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” in their application to the development of the virus triage detection system for the H1N1 virus. The patents can also be applied to detection systems for other viruses and biological threats such as Methicillin-resistant Staphylococcus aureus (MRSA).
CHIP trades as high as $3.87 intraday, a 237% gain from last Friday's close.
Quotes/News/Charts
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment